CELU Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

1 Analyst Rating

Wall Street analysts forecast CELU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELU is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

6.00

Averages

6.00

High

6.00

Current: 0.000

Low

6.00

Averages

6.00

High

6.00

No data

Valuation Metrics

The current forward P/E ratio for Celularity Inc (CELU.O) is -0.29, compared to its 5-year average forward P/E of -3.39. For a more detailed relative valuation and DCF analysis to assess Celularity Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-3.39

Current PE

-0.29

Overvalued PE

0.52

Undervalued PE

-7.29

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-2.28

Current EV/EBITDA

-0.67

Overvalued EV/EBITDA

1.45

Undervalued EV/EBITDA

-6.02

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

20.62

Current PS

0.52

Overvalued PS

62.64

Undervalued PS

-21.41

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

CELU News & Events

Events Timeline

No data

News

7.0

2025-12-29NASDAQ.COM

Celularity's Biovance Products to Maintain Medicare Coverage Post LCD Withdrawal

7.0

2025-12-26Globenewswire

Celularity Withdraws Skin Substitute LCDs; Biovance® Remains Medicare Eligible

7.0

2025-12-26Newsfilter

Celularity Responds to CMS Withdrawal of Skin Substitute Policies

People Also Watch

Frequently Asked Questions

What is Celularity Inc (CELU) stock price today?

The current price of CELU is 1.3 USD — it has increased 3.17 % in the last trading day.

What is Celularity Inc (CELU)'s business?

Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.

What is the price predicton of CELU Stock?

What is Celularity Inc (CELU)'s revenue for the last quarter?

Celularity Inc revenue for the last quarter amounts to 5.28M USD, decreased -43.16 % YoY.

What is Celularity Inc (CELU)'s earnings per share (EPS) for the last quarter?

Celularity Inc. EPS for the last quarter amounts to -0.88 USD, increased 20.55 % YoY.

What changes have occurred in the market's expectations for Celularity Inc (CELU)'s fundamentals?

The market is revising No Change the revenue expectations for CELU for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -38.97%.

How many employees does Celularity Inc (CELU). have?

Celularity Inc (CELU) has 123 emplpoyees as of January 10 2026.

What is Celularity Inc (CELU) market cap?

Today CELU has the market capitalization of 37.49M USD.